Remove Capital Market Remove IPO Remove Valuation
article thumbnail

Frequently Asked Questions for Private Companies Considering a Reverse Merger

JD Supra: Mergers

*This piece appears in PitchBook’s 2023 Annual US VC Valuations Report. We believe this is the wrong question—we view a reverse merger as "going public" during your cross-over round, rather than as an alternative to an IPO. By: Mintz - Securities & Capital Markets

Mergers 175
article thumbnail

Capital Markets vs. Investment Banking: Deals, Careers, Recruiting, Exits, and Offer Decisions

Mergers and Inquisitions

Even though we’ve covered industry groups vs. product groups and teams such as M&A , ECM , DCM , and Leveraged Finance , we continue to get questions about capital markets vs. investment banking. The questions usually go like this: Are capital markets teams (ECM, DCM, and LevFin) “real” investment banking?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Michael Mufson Discusses Investment Banking and Business Exit Strategies

How2Exit

Throughout his career, he has been instrumental in underwriting IPOs for family-held businesses and tracking the evolution of private equity. The discussion dives deep into the evolution of the capital markets, the rise of private equity, and the intricate process behind selling a business.

article thumbnail

Highlights from Cooley’s M&A Dealmakers Roundtable: SPACs!

Cooley M&A

is the increased frequency at which SPAC IPOs are occurring. As reflected in Chart 1 , 102 SPAC IPOs have been announced this year as of September 18, 2020—almost double the number of SPAC IPOs in all of last year (and more than double the number of SPAC IPOs in 2018). SPAC vs. IPO. Valuation Certainty.

M&A 52
article thumbnail

Joint trade associations highlight equity, fixed income and market data concerns ahead of upcoming Mifir review

The TRADE

The Mifid/r review forms a key base for the completion of a Capital Markets Union (CMU) that works for investors and issuers, a necessary element to ensure that EU capital markets across asset classes are more integrated and competitive globally.

Trading 59
article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

Amid depressed valuations, biotechnology companies also saw an increasing number of demands from activist investors that in certain cases led to more deal activity. It’s a more challenging market environment right now than we’ve seen in many years,” said Charlie Kim , who co-chairs Cooley’s capital markets practice.

M&A 40
article thumbnail

Cooley’s 2020 Tech M&A Year in Review

Cooley M&A

Despite dealmaking anxieties in the first half of the year, valuations remained strong, and discount opportunities were few and far between. 4] SPACs are neither shiny nor new, but many have argued that the pricing certainty afforded by SPACs contributed to their boom during an unpredictable market. A SPAC-tacular Year.

M&A 40